A clinical trial investigating best coronavirus (COVID-19) vaccine dose interval for pregnant women

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 09 Aug 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Aug 2021 New trial record
03 Aug 2021 According to Department of Health and Social Care and Nadhim Zahawi MP media release, Professor Paul is chief investigator of this trial, and this trial will run across 13 National Institute for Health Research (NIHR) sites in England including in London, Liverpool and Leeds
03 Aug 2021 According to Department of Health and Social Care and Nadhim Zahawi MP media release, initial results from this study expected by the end of the year.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com